Wiley acquired SimBioSys
An interesting news snippet.
Wiley acquired SimBioSys, a scientific software provider of tools used in the drug discovery process. Chemists use these tools, including the ARChem - Route Designer, to perform organic synthesis (designing synthetic routes for target molecules). ARChem’s organic chemistry system is derived from databases such as Wiley’s ChemInform Reaction Library (CIRX). The Canada-based company is privately held, and terms of its agreement with Wiley were not disclosed.
“By combining our traditional published content and databases with machine learning algorithms, we can support chemists in innovative research as they advance world knowledge” while using Wiley Science Solutions, says Steve Miron, Wiley’s SVP of global research.
I can see that logic behind acquiring ARChem since it allows them to better leverage their reaction databases, but I wonder what this means for some of the other Symbiosis tools in particular things like eHits?